Chronic Lymphocytic Leukemia Patients with IGHV Genes Carrying Only Silent Mutations Have A Longer Time From Diagnosis to Initial Therapy Than Patients Expressing B-Cell Receptors with No Somatic Mutations
Year: 2011
Type: article
Source: Blood
Authors: Matthew Kaufman, Xiao J. Yan, Emanuela M. Ghia, Donna Neuberg, Laura Z. Rassenti, Kostas Stamatopoulos, Paolo Ghia, David G Oscier, Frederic Davi, Richard Rosenquist, Chrysoula Belessi, Zadie Davis, Andreas Agathangelidis, Neil Kay, John C. Byrd, Jennifer R Brown, Kanti R. Rai, Thomas J. Kipps, Nicholas Chiorazzi
Institutions: Long Island Jewish Medical Center, Feinstein Institute for Medical Research, University of California San Diego, Moores Cancer Center, Dana-Farber Cancer Institute, G. Papanikolaou General Hospital, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Royal Bournemouth Hospital, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Uppsala University, General Hospital of Nikea, Mayo Clinic, The Ohio State University, Northwell Health
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2538155255